Patients affected by type 1 diabetes (T1D) suffer from lack of insulin secretion by the
pancreas, due to the autoimmune destruction of the insulinproducing beta cells. This …

A new approach to automatically regulate the glucose level in type 1 diabetes is presented
in this work. This is the so-called Automatic Regulation of Glucose (ARG) algorithm, which is …

Type 1 diabetes mellitus is a disease that affects millions of people around the world. Recent
progress in embedded devices has allowed the development of artificial pancreas that can …

An adaptive and personalized multivariable artificial pancreas (mAP) system using plasma
insulin estimates is proposed to efficiently accommodate major disturbances to the blood …

Diabetes is a chronic illness all over the world, and is one of the fastest growing global
health emergencies of the 21st century. Since diabetes is a multi-system disease requiring …

In this work the real-time estimation of plasma insulin concentration (PIC) to quantify the
insulin in the bloodstream in patients with type 1 diabetes mellitus (T1DM) is presented. To …

Background: The artificial pancreas (AP) system, a technology that automatically administers
exogenous insulin in people with type 1 diabetes mellitus (T1DM) to regulate their blood …

Human serum is a huge bioinformatics database of human physiological and pathological
state, many proteins/peptides among which can serve as biomarkers for monitoring human's …

In this study, an adaptive backstep** method is proposed to regulate the blood glucose
induced by meals for type-1 diabetic patients. The backstep** controller is used to control …

Abstract Background and Objective: Although there has been significant progress towards
closed-loop type 1 diabetes mellitus (T1DM) treatments, most diabetic patients still treat this …